|
Report Date : |
10.01.2013 |
IDENTIFICATION DETAILS
|
Name : |
COPERMED
COMERCIAL IMPORTADORA LTDA. |
|
|
|
|
Registered Office : |
Rodovia Jk,
Km,111 S/Nº - Chaves 37550-000 - Pouso Alegre/Mg |
|
|
|
|
Country : |
Brazil |
|
|
|
|
Financials (as on) : |
31.12.2011 |
|
|
|
|
Date of Incorporation : |
09.07.2007 |
|
|
|
|
Legal Form : |
Limited Liability
Company |
|
|
|
|
Line of Business : |
Wholesale of
Pharmaceuticals. |
|
|
|
|
No. of Employees : |
11 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 30th, 2012
|
Country Name |
Previous Rating (31.03.2012) |
Current Rating (30.06.2012) |
|
Brazil |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Brazil - ECONOMIC OVERVIEW
Characterized by large and well-developed agricultural, mining, manufacturing, and service sectors, Brazil's economy outweighs that of all other South American countries, and Brazil is expanding its presence in world markets. Since 2003, Brazil has steadily improved its macroeconomic stability, building up foreign reserves, and reducing its debt profile by shifting its debt burden toward real denominated and domestically held instruments. In 2008, Brazil became a net external creditor and two ratings agencies awarded investment grade status to its debt. After strong growth in 2007 and 2008, the onset of the global financial crisis hit Brazil in 2008. Brazil experienced two quarters of recession, as global demand for Brazil's commodity-based exports dwindled and external credit dried up. However, Brazil was one of the first emerging markets to begin a recovery. In 2010, consumer and investor confidence revived and GDP growth reached 7.5%, the highest growth rate in the past 25 years. Rising inflation led the authorities to take measures to cool the economy; these actions and the deteriorating international economic situation slowed growth to 2.7% for 2011 as a whole, though forecasts for 2012 growth are somewhat higher. Despite slower growth in 2011, Brazil overtook the United Kingdom as the world's seventh largest economy in terms of GDP. Urban unemployment is at the historic low of 4.7% (December 2011), and Brazil's traditionally high level of income equality has declined for each of the last 12 years. Brazil's high interest rates make it an attractive destination for foreign investors. Large capital inflows over the past several years have contributed to the appreciation of the currency, hurting the competitiveness of Brazilian manufacturing and leading the government to intervene in foreign exchanges markets and raise taxes on some foreign capital inflows. President Dilma ROUSSEFF has retained the previous administration's commitment to inflation targeting by the central bank, a floating exchange rate, and fiscal restraint.
|
Source : CIA |
COPERMED COMERCIAL IMPORTADORA LTDA.
|
MAIN ADDRESS: |
RODOVIA JK, KM,111
S/Nº - CHAVES |
|
ZIP CODE/CITY: |
37550-000 -
POUSO ALEGRE/MG |
|
|
|
|
PHONE: |
35 3425-2160 |
|
FAX: |
35 3422-9744 |
|
E-MAIL: |
copermed@bol.com.br |
|
WEB SITE: |
www.copermed.com |
BRANCHES:
DOES NOT HAVE
|
MAIN ACTIVITIES: |
|
WHOLESALE OF
PHARMACEUTICALS. |
|
LEGAL FORM: |
LIMITED LIABILITY COMPANY |
|
|
|
|
INCORPORATION
DATE: |
09/07/2007 |
|
REGISTER DATE: |
09/07/2007 |
|
BALANCE SHEET
FILING DATE: |
31/12 |
|
TAX CONTRIBUTOR
NUMBER(CNPJ): |
09.029.404/0001-82 |
|
STATE REGISTER: |
001.042.00000-97 |
|
|
|
|
SHARE CAPITAL: |
R$ 12.600,00 |
|
BOARD OF DIRECTORS: |
|
|
|
|
|
BRUNO ALEXANDRE
DEMORI |
MANAGING
PARTNER |
|
THE MANAGER IS AUTHORIZED
TO SIGN ON BEHALF OF THE COMPANY. |
|
SHAREHOLDERS / PARTNERS: |
|
|
|
|
|
ANGELO EURICO
DEMORI (DECEASED) |
99% |
|
BRUNO ALEXANDRE
DEMORI |
1% |
|
AFFILIATES / SUBSIDIARIES: |
|
|
|
|
|
NO SHARE
INTERESTS IN OTHER COMPANIES WERE NOTED |
|
THE SUBJECT WAS
ESTABLISHED ON JULY 9, 2007 TO BE ENGAGED IN THE SAID LINE OF BUSINESS.
WE HAVE TALKED TO
MR. REINER, DIRECTOR, WHO STATED THAT THE SUBJECT USED TO HAVE ANOTHER PARTNER THAT
DUE TO MISMANAGEMENT WAS FORCED TO LEAVE THE PARTNERSHIP. ACCORDING TO LAW AS
FROM JUNE 05, 2008 THE COMPANY HAD 180 DAYS TO RECOMPOUND THE PARTNERSHIP.
HOWEVER, SO FAR THE COMPANY REMAINS OPERATING AS SOLE PROPRIETORSHIP AND THE
SOLE PARTNER WILL BE UNLIMITEDLY LIABLE FOR ANY LIABILITY.
THE COMPANY
OPERATES WITH THE TRADE NAME OF "COPERMED"
PARTNERS:
ANGELO EURICO
DEMORI: REPRESENTED BY BRUNO ALEXANDRE DEMORI
BRUNO ALEXANDRE
DEMORI: BRAZILIAN, SINGLE, HOLDER OF DOCUMENTS CPF 376.360.938-55, RG 44.553.570-2,
SSP/SP, RESIDENTIAL ADDRESS AT RODOVIA J.K. 111, S/N, POUSO ALEGRE/MG.
FURTHER DETAILS
ABOUT THE SUBJECT'S HISTORY ARE SO FAR NOT KNOWN.
|
PUBLIC INFORMATION: |
|
LAWSUITS: |
|
|
|
|
DATE: |
COURT OF LAW: |
|
1 |
STATE LAWSUIT |
24/03/10 |
2ª VARA DE
POUSO ALEGRE/MG |
GENERAL BALANCE SHEETS AS OF 31/12/2011 AND
31/12/2010.
( FIGURES ARE IN
REAIS ).
|
ASSETS |
|
|
|
|
CURRENT: |
31/12/2011 |
31/12/2010 |
|
|
|
|
|
|
|
CASH AND CASH
EQUIVALENTS |
148.535,47 |
131.636,77 |
|
|
CLIENTS |
180.432,59 |
94.623,74 |
|
|
ADVANCE TO
SUPPLIERS |
144.960,13 |
60.760,13 |
|
|
ADVANCES |
59.781,00 |
|
|
|
RECOVERABLE
TAXES |
25.987,09 |
11.518,92 |
|
|
INVENTORY |
368.452,58 |
423.067,57 |
|
|
|
---------------- |
---------------- |
|
|
TOTAL CURRENT
ASSETS |
928.148,86 |
721.607,13 |
|
|
LONG-TERM RECEIVABLES: |
|
|
|
|
|
|
|
|
|
ACCOUNTS
RECEIVABLES |
501.405,59 |
|
|
|
|
---------------- |
---------------- |
|
|
TOTAL LONG-TERM
RECEIVABLES |
501.405,59 |
|
|
|
FIXED ASSETS: |
|
|
|
|
|
|
|
|
|
FIXED ASSETS |
267.979,04 |
109.127,67 |
|
|
|
---------------- |
---------------- |
|
|
TOTAL FIXED
ASSETS |
267.979,04 |
109.127,67 |
|
|
|
================ |
================ |
|
|
TOTAL ASSETS |
1.697.533,49 |
830.734,80 |
|
|
LIABILITIES: |
|
|
|
|
CURRENT: |
31/12/2011 |
31/12/2010 |
|
|
|
|
|
|
|
LABOR
OBLIGATIONS |
96.920,13 |
58.080,10 |
|
|
TRIBUTARY
OBLIGATIONS |
207.314,03 |
99.996,25 |
|
|
FINANCING |
12.196,32 |
41.666,67 |
|
|
SUPPLIERS |
1.037.499,86 |
516.313,25 |
|
|
OTHER |
11.443,72 |
|
|
|
|
---------------- |
---------------- |
|
|
TOTAL CURRENT
LIABILITIES |
1.365.374,06 |
716.056,27 |
|
|
LONG TERM LIABILITIES: |
|
|
|
|
|
|
|
|
|
LOANS AND
FINANCING |
27.865,71 |
52.306,40 |
|
|
|
---------------- |
---------------- |
|
|
TOTAL LONG TERM
LIABILITIES |
27.865,71 |
52.306,40 |
|
|
NET EQUITY: |
|
|
|
|
|
|
|
|
|
SHARE CAPITAL |
12.600,00 |
12.600,00 |
|
|
ACCRUED PROFIT
(LOSS) |
291.693,72 |
49.772,13 |
|
|
|
---------------- |
---------------- |
|
|
TOTAL NET
EQUITY |
304.293,72 |
62.372,13 |
|
|
|
================ |
================ |
|
|
TOTAL
LIABILITIES |
1.697.533,49 |
830.734,80 |
|
PROFIT AND LOSS
ACCOUNTS AS OF 31/12/2011 AND 31/12/2010.
( FIGURES ARE IN
REAIS ).
|
|
31/12/2011 |
31/12/2010 |
|
|
|
|
|
|
|
GROSS SALES |
3.860.020,75 |
2.347.480,15 |
|
|
(-) TAXES ON
SALES |
396.309,96 |
234.388,71 |
|
|
|
---------------- |
---------------- |
|
|
NET SALES |
3.463.710,79 |
2.113.091,44 |
|
|
(-) COST OF
SOLD GOODS |
2.077.185,32 |
1.022.365,83 |
|
|
|
---------------- |
---------------- |
|
|
GROSS PROFIT |
1.386.525,47 |
1.090.725,61 |
|
|
OPERATING REVENUE
(EXPENSE) |
-986.278,32 |
-703.367,45 |
|
|
FINANCIAL
REVENUE(EXPENSE) |
-60.697,34 |
-64.076,21 |
|
|
|
---------------- |
---------------- |
|
|
OPERATIONAL
PROFIT (LOSS) |
339.549,81 |
323.281,95 |
|
|
CONTRIBUTION/INCOME
TAX |
-97.628,22 |
-52.811,19 |
|
|
|
---------------- |
---------------- |
|
|
NET PROFIT
(LOSS) |
241.921,59 |
270.470,76 |
|
|
MONTHLY SALES |
|||
|
|
2012 |
|
|
|
|
--------------------- |
|
|
|
JANUARY |
R$ 432.249,24 |
|
|
|
FEBRUARY |
R$ 309.313,22 |
|
|
|
MARCH |
R$ 595.717,10 |
|
|
|
APRIL |
R$ 920.189,07 |
|
|
|
MAY |
R$ 1.012.715,25 |
|
|
|
JUNE |
R$ 698.618,33 |
|
|
|
JULY |
R$ 990.056,90 |
|
|
|
AUGUST |
R$ 1.296.155,35 |
|
|
|
SEPTEMBER |
R$ 1.055.068,20 |
|
|
|
OCTOBER |
R$ 1.088.754,02 |
|
|
|
NOVEMBER |
R$ 926.125,77 |
|
|
|
DECEMBER |
|
|
|
|
TOTAL |
R$ 9.324.962,45 |
|
|
|
RATIOS: |
31/12/2011 |
31/12/2010 |
|
|
QUICK RATIO |
,41 |
|
,42 |
|
|
|
|
CURRENT RATIO |
,68 |
|
1,01 |
|
|
|
|
ACCOUNTS
RECEIVABLE TURNOVER |
19,20 |
TIMES |
22,33 |
TIMES |
|
|
|
DAYS' SALES IN
RECEIVABLES |
18,75 |
DAYS |
16,12 |
DAYS |
|
|
|
INVENTORY
TURNOVER |
5,64 |
TIMES |
2,42 |
TIMES |
|
|
|
ACCOUNTS
PAYABLE PERIOD |
179,81 |
DAYS |
181,81 |
DAYS |
|
|
|
RETURN ON
ASSETS |
2,04 |
TIMES |
2,54 |
TIMES |
|
|
|
SALES TURNOVER
ON NET EQUITY |
11,38 |
TIMES |
33,88 |
TIMES |
|
|
|
NET WORTH
TIE-UP |
,88 |
|
1,75 |
|
|
|
|
INDEBTEDNESS |
4,58 |
|
12,32 |
|
|
|
|
EQUITY RATIO |
17,93 |
% |
7,51 |
% |
|
|
|
WORKING CAPITAL
RATIO |
-32,02 |
% |
,78 |
% |
|
|
|
GENERAL
SOLVENCY |
1,22 |
|
1,08 |
|
|
|
|
RETURN ON NET
EQUITY |
79,50 |
% |
433,64 |
% |
|
|
|
RETURN ON SALES
(PROFIT MARGIN) |
6,98 |
% |
12,80 |
% |
|
|
|
GROSS PROFIT MARGIN |
40,03 |
% |
51,62 |
% |
|
|
|
OPERATIONAL
RESULT |
9,80 |
% |
15,30 |
% |
|
|
|
SALES TURNOVER
ON LIABILITIES |
2,54 |
TIMES |
2,95 |
TIMES |
|
|
|
FOREIGN
CURRENCY ON ASSETS |
|
|
|
|
|
|
|
FOREIGN
CURRENCY ON LIABILITIES |
|
|
|
|
|
|
|
EXCHANGE RATE: |
|
|
US$ 1,00 = R$
2,04 |
- OFFICIAL RATE ON 04/01/2013 |
|
US$ 1,00 = R$
1,87 |
- OFFICIAL RATE ON 31/12/2011 |
|
US$ 1,00 = R$
1,66 |
- OFFICIAL RATE ON 31/12/2010 |
COMMENTS ON THE FINANCIAL INFORMATION:
FOLLOWS ATTACHED
WORKSHEET WITH MAIN FINANCIAL RATIOS.
THE FIGURES
AVAILABLE SHOW A FAIR FINANCIAL STANDING. THE LEVEL OF INDEBTEDNESS IS VERY
HIGH AND IT IS NOTED LOW CURRENT RATIO. ON THE OTHER HAND IT SHOWS REMARKABLE
GROWING SALES AND PROFITABILITY.
REMARKS:
--------
A REQUEST FOR
CLARIFICATION ABOUT THE INCREASE IN THE SALES VOLUME HAS BEEN SENT TO THE
COMPANY. PROVIDED THE DATA REQUESTED ARE RECEIVED FROM THE SUBJECT A
COMPLEMENTARY REPORT WILL BE SEND TO YOUR ATTENTION.
REAL ESTATE:
OWNED PREMISES ARE
VALUED AT R$ 150.000,00
THE PARTNERS OWN
REAL ESTATE VALUED AT R$ 350.000,00
VEHICLES:
OWNED VEHICLES ARE
VALUED AT R$ 114.890,00
MACHINES:
OWNED MACHINES AND
EQUIPMENTS ARE VALUED AT R$ 31.459,40
|
INSURANCE COMPANY: |
BRADESCO
SEGUROS |
|
COVERAGE: |
INVENTORY
(ROBBERY / FIRE) |
|
VALUE: |
R$ 500.000,00 |
|
|
BRANCH/PHONE: |
CITY: |
|
BANCO ITAÚ S/A |
7347 |
POUSO ALEGRE/MG |
|
BANCO DO BRASIL
S/A |
0368-9 /
35 3449-4600 |
|
REMARKS: IN BRAZIL
THE BANKS ARE PROHIBITED BY LAW TO PROVIDE INFORMATION OR ANY KIND OF COMMENTS
ABOUT THEIR CLIENTS. DUE TO THIS LAW PROHIBITION WE ARE UNABLE TO PROVIDE ANY
BANKING DETAILS.
ACCORDING TO THE
CENTRAL BANK OF BRAZIL OFFICIAL REPORT, THE COMPANY HAS RETURNED CHECKS UP TO
DATE. (IN THE TERMS OF "CIRCULAR 1682 BRAZILIAN CENTRAL BANK"). DATE
RESEARCHED: JANUARY 04, 2013.
WHOLESALE OF
PHARMACEUTICALS.
|
IMPORT AND EXPORT: |
IMPORTS FROM:
|
INDIA AND
EUROPE. |
EXPORTS TO:
|
ARGENTINA, URUGUAY, PARAGUAY AND CHILE. |
|
MAIN CLIENTS: |
|
|
|
|
|
|
|
DOMESTIC CLIENTS: |
|
PHONE: |
|
ADRIVAN |
|
11 4043-0411 |
|
BELFAR
INDUSTRIA FARMACEUTICA |
|
31 3492-1100 |
|
CIMED IN.
MEDICAMENTOS LTDA |
|
11 3544-7200 |
|
FAGRON DO
BRASIL FARMACEUTICA LTDA |
|
11 5033-3700 |
|
HYPERMARCAS S/A |
|
62 3310-2500 |
|
HYPOFARMA INST.
HYPODERMA |
|
31 3626-9019 |
|
LABORATORIO
TEUTO |
|
62 3310-2088 |
|
MEDQUIMICA |
|
32 3222-1433 |
|
NEO QUIMICA |
|
62 3310-2400 |
|
NOVAFARMA
INDUSTRIA FARMACEUTIVA |
|
62 3310-8200 |
|
ROYTON
INDUSTRIA FARMACEUTICA |
|
11 2107-9008 |
|
VALDEQUIMICA
PRODUTOS QUIMICOS |
|
11 3721-6407 |
|
STAFF: |
|
|
|
THE COMPANY
HAS: 11 EMPLOYEE(S) |
|
THE SUBJECT WAS ESTABLISHED
IN 2007. SO FAR IT HAS A CLEAR TRADE HISTORY AND NORMAL PAYMENT BEHAVIOUR. THE COMPANY HAS
TRADE RELATIONS WITH SOME LOCAL SUPPLIERS BUT UP TO DATE ONLY SMALL PAYMENTS
WERE REPORTED AND THE SUBJECT IS NOT SAID TO BE USER OF TRADE CREDIT FACILITIES. THE LAWSUIT REPORTED IS NOT RELATED WITH
TRADE DEBT. IT IS RELATED TO TAX DEBT THAT FOR ANY REASON THE COMPANY HAS NOT
YET PAID. NEVERTHELESS WE POINT OUT THAT THE SAID LAWSUIT DOES NOT AFFECT THE
COMPANY’S TRADE REPUTATION.
|
|
MAIN SUPPLIERS: |
|
|
|
|
|
|
|
DOMESTIC SUPPLIERS: |
|
PHONE: |
|
OURO FINO SAUDE
ANIMAL LTDA |
|
16 3518-2326 |
|
PAULINERIS
TRANSPORTES E ENCOMENDAS LTDA |
|
35 3422-8935 |
|
PHARMASAIS COM.
DIS. ESP.FARMACEUTICA LTDA |
|
11 3806-1760 |
|
FOREIGN SUPPLIERS: |
COUNTRY: |
|
|
DP PHARM CHEM |
GERMANY |
|
|
INDOCO REMEDIES |
INDIA |
|
|
JIANGSU GUOTAI
INTERN. GROUP |
CHINA |
|
|
LACTOSE INDIA
LTD |
INDIA |
|
|
SINOCHEM
LIAONING |
CHINA |
|
|
SURYA
PHARMACEUTICALS |
INDIA |
|
|
PAYMENT HISTORY: |
|
2 SUPPLIERS
REPORTED PAYMENTS: |
|
TOTAL AMOUNT: R$ 10.299,00 |
|
|
|
AMOUNT OF
INVOICES PAID: 3 |
|
TOTAL OF PROMPT
PAYMENTS: 100% |
|
HIGHEST
INVOICE: R$ 1.136,00 |
|
HIGHEST CREDIT:
R$ 1.136,00 |
BASED ON THE GENERAL
INFORMATION AVAILABLE IT IS BELIEVED THAT GOOD TRADE RELATIONS MAY BE
ESTABLISHED. CREDIT FACILITIES MAY BE EXTENDED WITHIN TERMS AND AMOUNTS
ADEQUATE TO THE COMPANY’S FINANCIAL STRENGTH.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.54.96 |
|
UK Pound |
1 |
Rs.88.23 |
|
Euro |
1 |
Rs.71.92 |
INFORMATION DETAILS
|
Report Prepared
by : |
SDA |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.